AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2019
Jan 9, 2019
31046_dirs_2019-01-09_28207960-689c-4b58-96b9-d957a0a6bec1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-01-07
Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-07 | Common Stock | S | 1764 | $34.75 | Disposed | 24882 | Direct |
| 2019-01-07 | Common Stock | S | 339 | $34.75 | Disposed | 17947 | Indirect |
| 2019-01-07 | Common Stock | S | 409 | $34.75 | Disposed | 17538 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right To Buy) | $451.2 | 2019-05-15 | Common Stock (41.0) | 41 | Indirect |
| Stock Option (Right To Buy) | $1149.6 | 2020-02-02 | Common Stock (37.0) | 37 | Indirect |
| Stock Option (Right To Buy) | $490.8 | 2021-04-27 | Common Stock (58.0) | 58 | Indirect |
| Stock Option (Right To Buy) | $218.4 | 2022-01-10 | Common Stock (38.0) | 38 | Indirect |
| Stock Option (Right To Buy) | $10.85 | 2023-05-15 | Common Stock (3900.0) | 3900 | Indirect |
| Stock Option (Right To Buy) | $27.05 | 2024-01-28 | Common Stock (4900.0) | 4900 | Indirect |
| Stock Option (Right To Buy) | $51.0 | 2025-01-02 | Common Stock (10880.0) | 10880 | Indirect |
| Stock Option (Right To Buy) | $30.86 | 2026-01-03 | Common Stock (11000.0) | 11000 | Indirect |
| Stock Option (Right To Buy) | $12.64 | 2026-11-16 | Common Stock (2000.0) | 2000 | Indirect |
| Stock Option (Right To Buy) | $11.23 | 2027-01-02 | Common Stock (12600.0) | 12600 | Indirect |
| Stock Option (Right To Buy) | $18.01 | 2028-01-02 | Common Stock (30625.0) | 30625 | Indirect |
Footnotes
F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares of restricted stock.
F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs.
F3: Includes: 1) 1,950 unvested RSUs from an award of 3,900 RSUs granted on January 3, 2017, which vests in four equal annual installments over four years, commencing on January 3, 2018; and 2) 5,250 shares of restricted stock granted on January 3, 2018, which vest in four equal annual installments over four years, commencing on January 3, 2019.
F4: The reporting person acquired beneficial ownership of these securities upon his marriage to the owner of the securities in 2018.
F5: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,312 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock.
F6: Currently exercisable.
F7: This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
F8: This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
F9: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
F10: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.